ELPEN Pharmaceutical Co. Inc.

Exhibitor at CPHI Frankfurt 2025 stand 9.1B24, Integrated Pharma

About Us

Elpen is the leading greek pharmaceutical company with presence in more than 90 countries. The company develops and produces branded generics and value added medicines across different technologies and therapeutic areas, investing more than 10% of its annual turnover into Research & Development. Since 2012, the company has established ELPEN Pharma GmbH, a subsidiary in Germany and in 2024 established its subsidiary in Dubai.

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

CPHI Online is the largest global marketplace in the pharma ingredients industry

ELPEN Pharmaceutical Co. Inc.

About Us

Sales Markets

Categories

CPHI Online is the largest global marketplace in the pharma ingredients industry

ELPEN Pharmaceutical Co. Inc.

About Us

Sales Markets

Categories

Position your company at the heart of the global Pharma industry with a CPHI Online membership

Coming soon

ELPEN Pharmaceutical Co. Inc.

Address

Telephone

Website

Request for general information

Send a message to Please review your profile details to ensure it is up-to-date.

Send a message to
Please review your profile details to ensure it is up-to-date.